ArticleJournal of cellular and molecular medicine2024
Correction to Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.